The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Riedell, Peter
Item TypeName
Concept Immunotherapy, Adoptive
Academic Article Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma.
Academic Article Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
Academic Article Advances in CAR T-Cell Therapy for Aggressive B-NHL.
Academic Article Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
Academic Article Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL.
Academic Article Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
Academic Article Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.
Academic Article Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial.
Academic Article Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy.
Academic Article Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Academic Article Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
Academic Article Infectious complications of car T-cell therapy: A longitudinal risk model.
Academic Article Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma.
Academic Article Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
Academic Article If They RECUR, You Should Refer: A Community Oncologist Patient ID Roundtable Summary.
Academic Article Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Academic Article Optimization of older adults by a geriatric assessment-guided multidisciplinary clinic before CAR T-cell therapy.
Academic Article Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis.
Academic Article CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience.
Academic Article Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis.
Academic Article Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.
Academic Article BsAbs before CD19 CAR-T: full speed ahead!
Search Criteria
  • Immunotherapy